SCHEMBL369762

SCHEMBL369762

C=CCC(CO)CC=C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45005 0.93
SCHEMBL4625271 0.88 TSHR (0.37)
SCHEMBL9284591 0.83
Butane SCHEMBL8140546 0.83 ALDH1A1 (0.37)
SCHEMBL17078026 0.83
SCHEMBL25276063 0.83
SCHEMBL731752 0.83
SCHEMBL2541103 0.83
SCHEMBL12186681 0.79
SCHEMBL18222618 0.79

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 238 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260007786-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES SPAGO NANOMEDICAL AB (SE) 2026-01-08 US disclosed
US-20250268903-A1 RXFP1 AGONISTS BRISTOL MYERS SQUIBB CO (US) 2025-08-28 US disclosed
EP-4490218-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES Spago Nanomedical AB (SE) 2025-01-15 EP disclosed
CN-118922471-A Compounds for coating nanostructures 斯帕果纳米医学有限公司 2024-11-08 CN disclosed
EP-4423058-A1 RXFP1 AGONISTS Bristol-Myers Squibb Company (US) 2024-09-04 EP disclosed
CN-118451058-A RXFP1 agonists 百时美施贵宝公司 2024-08-06 CN disclosed
WO-2023172185-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES SPAGO NANOMEDICAL AB (SE) 2023-09-14 WO disclosed
EP-4242250-A1 COMPOUNDS FOR COATING OF NANOSTRUCTURES Spago Nanomedical AB (SE) 2023-09-13 EP disclosed
US-20230144449-A1 TERMINAL FUNCTIONAL SIDE CHAIN-SUBSTITUTED DIKETOPYRROLOPYRROLE (DPP)-BASED TERPOLYMER AND PREPARATION METHOD AND USE THEREOF BEIJING INSTITUTE OF GRAPHIC COMMUNICATION (CN) 2023-05-11 US disclosed
WO-2023077040-A1 RXFP1 AGONISTS BRISTOL-MYERS SQUIBB COMPANY (US) 2023-05-04 WO disclosed
US-5621098-A ALKYLATION OF THE CORRESPONDING BISINDOLE COMPOUND; CYCLIZATION; PROTEIN C KINEASE INHIBITOR ELI LILLY AND COMPANY (US) 1997-04-15 US disclosed
US-5552396-A BIS-INDOLEMALEIMIDE MACROCYCLIC DERIVATIVES, ELI LILLY AND COMPANY (US) 1996-09-03 US disclosed
EP-0657458-A1 Protein kinase C inhibitors ELI LILLY AND COMPANY (US) 1995-06-14 EP disclosed
US-5298572-A Reacting polyisocyanate, monol and organic polyacyl compounds, forming terminally unsaturated polymers, reacting with a dialkoxysilane and curing OLIN CORPORATION (US) 1994-03-29 US disclosed
US-4966993-A Process for preparation of 3-hydroxy-3-methyl-glutaric acid LABORATORI GUIDOTTI SPA (IT) 1990-10-30 US disclosed
US-4546203-A ONE-STEP OXIDATION OF 3-METHYL-1,3,5-PENTANETRIOL BY AN ALKALI PERMANGANATE IN AQUEOUS MEDIA AMERICAN HOECHST CORPORATION (US) 1985-10-08 US disclosed
EP-0082344-B1 PROCESS FOR PREPARING BETA-HYDROXY-BETA-METHYLGLUTARIC ACID AMERICAN HOECHST CORPORATION (US) 1985-09-18 EP disclosed
EP-0082344-A1 Process for preparing beta-hydroxy-beta-methylglutaric acid AMERICAN HOECHST CORPORATION (US) 1983-06-29 EP disclosed
US-4107115-A VINYL CHLORIDE HOMOPOLYMERS AND COPOLYMERS EMERY INDUSTRIES, INC. (US) 1978-08-15 US disclosed
US-4029682-A Soaps and ester-soaps of α-olefin derived high molecular weight acids EMERY INDUSTRIES, INC. (US) 1977-06-14 US disclosed